Yvonne Greenstreet, Chief Executive Officer at ALNYLAM PHARMACEUTICALS, INC. (ALNY), sold 11,484 shares at $149.03 ($1.7M) on 2024-02-16, disclosed to the SEC on 2024-02-20.
Open-market sale of $1.7M ALNY by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $147.50 | 2,576 | $380K | 22.3% |
| 2 | $148.24 | 3,614 | $536K | 31.5% |
| 3 | $148.24 | 3,614 | $536K | 31.5% |
| 4 | $149.03 | 840 | $125K | 7.4% |
| 5 | $149.03 | 840 | $125K | 7.4% |
| Total | $148.19 avg | 11,484 |
| $1.7M |
| 100% |
| Filing → |
| ALNY | SELL | 2026-02-17 | $2.2M | — | Filing → |
| ALNY | SELL | 2026-01-14 | $3.5M | — | Filing → |
| ALNY | SELL | 2025-11-14 | $23.2M | — | Filing → |